Davis, P., Cunnington, P., and Hughes, G. R. V. (1975). Annals ofthe Rheumatic Diseases, 34,239-243. Double-stranded RNA antibodies in systemic lupus erythematosus. Antibodies to viral double-stranded RNA (ds RNA) have been found in 40% ofpatients with systemic lupus erythematosus (SLE) and 14-5 % of patients with rheumatoid arthritis. These antibodies were diagnostically more specific for SLE than those directed against artificial polynucleotides, poly I: C and poly A: U. Although not disease specific, high titres of antibody to ds viral RNA were found almost exclusively in SLE. Serial studies failed to show that RNA antibody levels correlated with disease activity.
Systemic lupus erythematosus (SLE) is characterized by a wide variety of circulating antibodies. In particular, antibodies against double-stranded DNA (ds DNA) have been shown to have clinical significance in their diagnostic specificity and sensitivity in SLE (Hughes, 1971; Hughes, Cohen, and Christian, 1971) . Ofinterest has been the demonstration in SLE of antibodies directed against double-stranded RNA (ds RNA) (Schur and Monroe, 1969; . This finding, together with the fact that most human RNA is single stranded, has led to the suggestion that these antibodies may be directed against viral antigens (Schur, Stollar, Steinberg, and Talal, 1971) .
A variety ofmethods has been used in the detection of RNA antibodies, including the sensitive Farr technique (Wold, Young, Tan, and Farr, 1968 ) and the filter radioimmunoassay technique (Attias, Sylvester, and Talal, 1973) . The antigen most widely used in these techniques has been the synthetic polynucleotide poly inosinic:poly cytidylic acid (poly I: C), which has structural and chemical similarities to ds RNA. Using this technique, Schur and his colleagues (1971) detected antibodies against poly I: C in 51 % of SLE sera, but these were not specific, also being found in 9% of patients with rheumatoid arthritis (RA) and in 6 % of normals. In the present study we have substituted the synthetic polynucleotide poly I:C for a highly purified preparation of doublestranded viral RNA obtained from Penicillium cultures, and assessed the frequency and specificity of (Pincus, Schur, Rose, Decker, and Talal, 1969; Hughes, and others, 1971) . Measles antibody estimations were performed (by Dr. G. Agnirsdottir) using the haemagglutination-inhibition technique. Antibodies to viral RNA were measured using BRL 5907, an extract produced and purified from a Penicillium culture infected with ds RNA virus, by the method of Banks, Buck, Chain, Darbyshire, and Himmelweit (1969) , and labelled with tritium. The ds RNA when purified was essentially free from protein and had a sedimentation coefficient of 12S. It has a well-defined molecular weight composition of 2 x 106 and gave a single OD peak at 280 nm on Sepharose 2B chromatography. The ds RNA exhibited marked hyperchromicity and melting profile when heated and was much more resistant to bovine pancreatic ribonuclease than was single-stranded RNA (Cunnington and Naysmith, 1975 Inhibition studies were performed after preincubation at 37°C for 1 h with a twentyfold excess of nonradioactive ds and ss DNA, ds and ss RNA, and poly I: C and poly A:U.
Results
The incidence ofantibodies to the various nuclear and viral antigens tested are summarized in Table I . Using ds viral RNA, antibodies were found in 45 of 112 SLE sera tested (40 %). A significant but lower incidence of these antibodies was also found in 5 of 37 RA sera(14-5 %), 2 of 10 discoid LE sera (10%), and 1 of 39 normal controls (2-5 %). Levels of RNA antibodies in all groups are shown in Fig. 1 .
COMPARISON OF DS RNA AND SYNTHETIC POLYNUCLEOTIDES
Twenty-nine SLE sera in which ds RNA antibodies had been detected were also tested for the presence of antibodies to the synthetic polynucleotides, poly I: C and poly A: U. Antibodies to poly I: C were found in 66 % and to poly A: U in 13 % of these cases. Fig. 2 shows the relationship of viral RNA to poly I: C binding in SLE patients. A small number of sera appeared to react almost exclusively with viral RNA. Antibodies to poly I: C were detected in 17 of 32 RA sera tested (53 %). Only four of these patients had antibodies against ds RNA. Of the 27 patients with discoid LE tested, seven (27%) had antibodies to ds DNA as previously reported (Davis and Hughes, 1974 ). Two of twenty tested for ds RNA antibodies had slightly raised titres.
SERIAL STUDIES Serial studies (3 or more sequential measurements) were performed in six patients with SLE. In only one patient was there a direct correlation between a rising or falling titre of RNA antibodies and clinical activity. In two patients a consistently high RNA antibody titre was noted despite fluctuating disease activity and DNA binding activity. 
MEASLES
Measles antibody titres were measured in 21 patients with SLE. In our group titres were raised in 64% of cases and showed an overall, though indirect, correlation with raised levels of both ds DNA and ds RNA antibodies. In 9 sera from patients convalescing from measles infection and 5 with influenza, anti ds RNA and DNA antibodies were not detectable.
INHIBITION STUDIES
Inhibition studies were carried out on sera from six patients with high levels of viral RNA antibodies (Table II 
Discussion
Most recent attempts to detect and characterize anti-RNA antibodies have used the synthetic polynucleotides poly I: C and poly A: U. Schur and Monroe (1969) , using an Ouchterlony immunodiffusion method, detected antibodies against poly I: C in sixteen out of 89 SLE patients (18 %). Koffler, Agnello, Thorburn, and Kunkel (1971) , with a haemagglutination method again using poly I: C as the antigen, detected antibodies in 13 out of 60 SLE sera. Schur and others (1971) compared Ouchterlony immunodiffusion, microcomplement fixation, and the Farr ammonium sulphate precipitation method, using a variety of synthetic polynucleotides. Precipitating antibodies were found against poly I: C in 17% of SLE sera and 4 % of RA sera. Using the more sensitive Farr method, 51 % of SLE and 9% of RA sera showed raised binding activity against poly I: C. Attias and others (1973), using the more sensitive filter radioimmunoassay, found antibodies to rheovirus RNA in 70 % of SLE sera but in only 14 % of RA sera and 4 % of controls.
Our present studies, using viral RNA confirm the high incidence of antibodies to ds RNA in SLE. While it is shown that variable cross-reactivity of these antibodies with other polynucleotides may occur, it is possible that, as in the case of anti-DNA antibodies, a variety of anti-ds RNA antibodies with differing specificities may be found.
The origin of the antigen is at present unknown. Human RNA is predominantly single stranded, though transfer RNA has helical regions in its structure. However, Talal, Steinberg, and Daley (1971) failed to achieve significant inhibition of poly I:C binding by human SLE serum with transfer RNA. These and other observations have led to suggestions that the antigen may be viral in nature (Talal, 1970) . Raised antibody titres to a number of viruses, particularly myxoviruses, have been observed in SLE (Phillips and Christian, 1970) , though these increases may reflect the overall production of humoral antibodies characteristic of SLE. In our own series the mean H:I titre of measles antibodies was raised in the SLE group, confirming the original observations of Phillips and Christian, but there was no direct relationship between anti-ds RNA antibody and measles antibody titres. We were, equally, unable to detect anti-ds RNA antibodies in convalescent sera from other myxovirus infections. Schur and others (1971) found no increase in antibodies to ds RNA (poly I: C) after acute infection with influenza virus, despite fourfold rises in antibody titres to influenza A2 antigens.
Support for the antigenic RNA being viral in origin came from the observations of Talal and others (1971) who, using inhibition of binding of poly I: C by various RNAs, observed that sera from New Zealand mice immunized with synthetic RNA reacted poorly with viral RNA, whereas mice immunized with viral RNA reacted with both synthetic and viral RNA, as in the case of human lupus sera. A third possible source of antigen might be ds RNA induced in mammalian cells as a consequence of viral infection (Stollar and Stollar, 1970 (Talal, 1970) . It is possible that the genetic factors predisposing to the heightened production of antibodies to RNA in these animals may also be present in SLE.
From the clinical viewpoint, it is clear that in many human SLE sera, and in some patients with discoid LE, antibodies are present which are directed against erythematosus.
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